Apixaban

Description

Apixaban is the third new oral anticoagulant to be launched after dabigatran and rivaroxaban. It has been approved in Europe to prevent venous thromboembolic events in patients undergoing elective hip or knee replacement surgery.

Inquiry Us

Quantity：

Company Name：

Add：

Tel：

Fax：

Your Name *

Your Email *

Product Name

Your Message *